THEY SAID IT! R STREET CALLS FOR BIPARTISAN, MARKET-BASED SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Oct 14, 2026
Article Highlights How Congress Can Address Patent Thickets, Product Hopping… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 14, 2026
Big Pharma Giant Beats Earnings, Projects $100 Billion in Annual Sales… Read More
DOSE OF REALITY: JAMA STUDY FINDS DRUG PATENT PORTFOLIOS ON SMALL MOLECULE DRUGS HAVE MORE THAN TRIPLED, DELAYING GENERIC COMPETITION
Sep 30, 2026
New Analysis Shows Brand Name Drug Companies Increasingly Rely On Follow-On… Read More
DOSE OF REALITY: AARP ANALYSIS EXAMINES PATENT ABUSE ON BRAND NAME INHALER THAT KEPT PRICES HIGH FOR PATIENTS
Sep 30, 2026
Report Details How Tactics Like Patent Thicketing and Product Hopping Delayed… Read More
DOSE OF REALITY: BIOSIMILAR SLOWDOWN UNDERSCORES URGENCY FOR SOLUTIONS TO FOSTER GREATER COMPETITION, ENCOURAGE BIOSIMILAR DEVELOPMENT
Sep 16, 2026
Congress Should Pass Bipartisan, Market-Based Solutions to Reduce Unnecessary… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY & NOVO NORDISK
Aug 21, 2026
Big Pharma Giants Smash Second Quarter Earnings After Price Hikes Across Their… Read More
BIG PHARMA EARNINGS WATCH: AMGEN, MERCK, GILEAD & PFIZER
Aug 10, 2026
Pharmaceutical Giants Beat Earnings Estimates Following Price Hikes to Start… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, BRISTOL MYERS SQUIBB & ABBVIE
Aug 4, 2026
Brand Name Drug Companies Tout Patent Strategies on Blockbusters That Block… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA & GSK
Jul 29, 2026
Brand Name Drug Companies Book Blockbuster Profits Following Price Hikes… Read More
CSRxP ANALYSIS: BIG PHARMA’S PROFIT MARGINS CLIMB TO 11 TIMES GREATER THAN OTHER SECTORS IN DRUG SUPPLY CHAIN
Jul 27, 2026
Brand Name Drug Companies Banking Ever Higher Profits Fueled by Egregious… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS & ROCHE
Jul 27, 2026
Big Pharma Giants Continue Topping Wall Street Expectations Following Price… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jul 17, 2026
Johnson & Johnson Tops Profit Expectations, Lifts Outlook Following Price… Read More